Post-Hospital Intervention for Veterans With Comorbid Bipolar and Substance Use Disorders
NCT ID: NCT04127604
Last Updated: 2025-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
138 participants
INTERVENTIONAL
2020-11-02
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention for Comorbid Substance Use and Bipolar Disorders
NCT04202393
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
NCT00007761
Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study
NCT00746343
Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites
NCT00747201
Improving Care for Patients With Bipolar Disorder
NCT00222755
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated Treatment Adherence Program for Veterans (ITAP-VA)
A combination of in-person and phone sessions along with significant other involvement over 6 months post-hospitalization.
Integrated Treatment Adherence Program for Veterans (ITAP-VA)
Psychosocial support and treatment to improve treatment adherence, symptoms, and functioning.
Safety Assessment and Follow-up Evaluation (SAFE)
Enhanced symptom monitoring and safety evaluation over 6 months post-hospitalization.
Safety Assessment and Follow-up Evaluation (SAFE)
Measurement-based care assessment and evaluation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrated Treatment Adherence Program for Veterans (ITAP-VA)
Psychosocial support and treatment to improve treatment adherence, symptoms, and functioning.
Safety Assessment and Follow-up Evaluation (SAFE)
Measurement-based care assessment and evaluation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of a substance use disorder (drug and/or alcohol)
* Taking at least one psychiatric medication
Exclusion Criteria
* Younger than age 18
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Providence VA Medical Center
FED
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jane Metrik, PhD
Role: PRINCIPAL_INVESTIGATOR
Providence VA Medical Center, Providence, RI
Brandon A Gaudiano, PhD
Role: PRINCIPAL_INVESTIGATOR
Providence VA Medical Center, Providence, RI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Providence VA Medical Center, Providence, RI
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-2019-027
Identifier Type: OTHER
Identifier Source: secondary_id
IIR 19-048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.